Production of monovalent anti-Bothrops asper antivenom: development of immune response in horses and neutralizing ability.

This study focuses on the production of a monovalent antivenom by immunizing horses with the venom of Bothrops asper, a species of pit viper. The researchers noted that the antivenom was particularly effective against B. Asper venom but less effective when used against other venoms. They conclude that the response to venom immunization can vary considerably between individual animals.

Development of Immune Response in Horses

• The research involved immunizing two horses with venom from Bothrops asper, a kind of pit viper snake. The goal was to stimulate an immune response in the horses and produce antivenom from their blood serum.
• While the horses’ immune response to the venom’s toxic and enzymatic activities was similar throughout most of the immunization schedule, one horse developed a significantly stronger antibody response during the last part of the schedule.
• Antibodies that precipitate, or cause an antigen to become solid, were present in the horses’ blood at all stages of the immunization. However, the presence of these antibodies did not correlate directly with the blood’s ability to neutralize the venom’s toxic activities.

Effectiveness of Monovalent Antivenom

• The monovalent antivenom (antivenom specific to one type of venom) produced from the horses’ blood was more effective than the commercially available polyvalent antivenom (antivenom effective against multiple types of venom) in neutralizing Bothrops asper venom. However, its effectiveness was lower when used against other types of venom from Lachesia muta and Crotalus durissus durissus.
• While the monovalent antivenom could neutralize the lethal and hemorrhagic activities of these venoms, it could not counteract their defibrinating activity (the ability to disrupt blood clotting). On the other hand, it could neutralize the defibrinating effect of B. asper venom.

Implications and Recommendations

• The results suggest that the monovalent antivenom could be particularly effective for treating bites from Bothrops asper snakes. It might also be useful in treating bites from L. muta and C. durissus if polyvalent antivenom is unavailable.
• The variability in immune response among horses highlights the need to monitor antibody response individually in order to effectively produce antivenom.